Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 10:2021:5554461.
doi: 10.1155/2021/5554461. eCollection 2021.

Role of MicroRNA-155 as a Potential Biomarker for Allergic Rhinitis in Children

Affiliations

Role of MicroRNA-155 as a Potential Biomarker for Allergic Rhinitis in Children

Noha M Hammad et al. Can Respir J. .

Abstract

Background: Allergic rhinitis (AR) is an inflammatory state categorized by a disturbance of immunoregulatory mechanisms. MicroRNA-155 (miRNA-155) has an essential role in regulating gene expression and can mediate the allergic TH2 process.

Objective: In this study, we aimed to evaluate the role of miR-155 as a biomarker in AR and correlate its level with the total nasal symptom score (TNSS) and the levels of serum interleukin-4 (IL-4).

Methods: This study included 90 children: 45 with pollen-induced AR and 45 healthy controls. Serum miR-155 expression levels were measured using quantitative real-time PCR. Human IL-4 ELIZA kits were used for the semiquantitative detection of the serum levels of IL-4. Receiver operating characteristic (ROC) curves were used to determine the best cutoff values for the studied parameters for the diagnosis of AR.

Results: The demographic characteristics of the two groups were matched with respect to age and sex. The AR case group included 23 (51.1%) males and 22 (48.9%) females, while the control group included 24 (53.3%) males and 21 (46.7%) females. The miR-155 level was increased in the serum of children with pollen-induced AR compared with controls (mean difference = 2.8, p < 0.001). A significant positive correlation between the serum expression level of miR-155 and TNSS in children with AR was detected (r = 0.494, p < 0.001). However, no significant correlation was identified between the expression of miR-155 and that of IL-4. At a cutoff value of 1.09, the sensitivity of miR-155 as a biomarker for AR was 100%, and the specificity was 71.1%.

Conclusion: MiR-155 expression levels were elevated in the serum of AR children. Therefore, miR-155 could be used as a biomarker in AR diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Comparison between the studied groups regarding (a) miR-155 and (b) IL-4 serum levels. AR: allergic rhinitis and SD: standard deviation.
Figure 2
Figure 2
ROC curve showing the performance of miRNA-155 and IL-4 in the diagnosis of allergic rhinitis.
Figure 3
Figure 3
Correlations between miR-155 and (a) TNSS, (b) IL-4, (c) specific IgE, and (d) age among AR patients.

Similar articles

Cited by

References

    1. Cheng L., Chen J., Fu Q., et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy, Asthma & Immunology Research. 2018;10(4):300–353. - PMC - PubMed
    1. Skoner D. P. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. The Journal of Allergy and Clinical Immunology. 2001;108:8. doi: 10.1067/mai.2001.115569. - DOI - PubMed
    1. Meltzer E. O. Quality of life in adults and children with allergic rhinitis. Journal of Allergy and Clinical Immunology. 2001;108(1):S45–S53. doi: 10.1067/mai.2001.115566. - DOI - PubMed
    1. Deo S., Mistry K., Kakade A., Niphadkar P. Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India. 2010;27(2):66–71. doi: 10.4103/0970-2113.63609. - DOI - PMC - PubMed
    1. Scadding G. Cytokine profiles in allergic rhinitis. Current Allergy and Asthma Reports. 2014;14(5):p. 435. doi: 10.1007/s11882-014-0435-7. - DOI - PubMed